PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

NCT07232069 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease Risk Factors Multiple
Coronary Artery Disease Progression
Prevention & Control
Premature Atherosclerosis

Interventions

DRUG: Rosuvastatin 20 Mg Oral Tablet
DRUG: Colchicine 0.5 MG Oral Tablet Once Daily
DRUG: Placebo

Sponsor

Duke University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]